IVIG is typically given in supervised outpatient settings, such as health clinics or infusion suites. It may also be given in ...
Systems announced the signing of an agreement with a global pharmaceutical company. The agreement is intended for KORU ...
In conclusion, we consider that the available data indicate that IVIg is not a lost cause for the therapy of MS 15,16, and that clinical trials are therefore warranted to determine if a ...
The nationally accredited home infusion teams at AIC collaborate closely ... partner with GC Biopharma to offer this extra-purified IVIg replacement therapy as another treatment option to patients ...